insights_auto
Why is EMCURE up ४.५७%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३३४.४०
arrow_upward
+४.५७%(+१०२.००) 1D
नोभेम्बर १२, १५:३०:०२ GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
Yahoo Finance
·
२ घण्टा पहिले
Michael Burry Doubles Down On Nasdaq 100 Puts, Adds To Semiconductor Shorts As Nvidia Faces Scrutiny
Investing.com Canada
·
३६ मिनेट पहिले
RadNet COO Mital Patel sells $3.5M in NASDAQ:RDNT stock
marketscreener.com
·
१ घण्टा पहिले
Mercer International Inc.(NasdaqGS: MERC) dropped from S&P TMI Index
WSJ
·
३ घण्टा पहिले
U.S. Stocks Down as Huang Ouster Sends Shockwaves Through Tech
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com